Monday, December 5, 2016

BRIEF-Neuroderm to replace two Phase 3 clinical trials with small pharmacokinetic trials

* Neuroderm to replace two Phase 3 clinical trials with

small pharmacokinetic trials following FDA meeting on ND0612

regulatory development

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)